Abstract：
UNASSIGNED: To analyze Hyperbaric Oxygen Therapy Registry (HBOTR) data to estimate the Medicare costs of hyperbaric oxygen therapy (HBO2) based on standard treatment protocols and the annual mean number of treatments per patient reported by the registry.
UNASSIGNED: We performed a secondary analysis of deidentified data for all payers from 53 centers registered in the HBOTR from 2013 to 2022. We estimated the mean annual per-patient costs of HBO2 based on Medicare (outpatient facility + physician) reimbursement fees adjusted to 2022 inflation using the Medicare Economic Index. Costs were calculated for the annual average number of treatments patients received each year and for a standard 40-treatment series. We estimated the 2022 costs of standard treatment protocols for HBO2 indications treated in the outpatient setting.
UNASSIGNED: Generally, all costs decreased from 2013 to 2022. The facility cost per patient per 40 HBO2 treatments decreased by 10.7% from $21,568.58 in 2013 to $19,488.00 in 2022. The physician cost per patient per 40 treatments substantially decreased by -37.8%, from $5,993.16 to $4,346.40. The total cost per patient per 40 treatments decreased by 15.6% from $27,561.74 to $23,834.40. In 2022, a single HBO2 session cost $595.86. For different indications, estimated costs ranged from $2,383.4-$8,342.04 for crush injuries to $17,875.80-$35,751.60 for diabetic foot ulcers and delayed radiation injuries.
UNASSIGNED: This real-world analysis of registry data demonstrates that the actual cost of HBO2 is not nearly as costly as the literature has insinuated, and the per-patient cost to Medicare is decreasing, largely due to decreased physician costs.
UNASSIGNED: We performed a secondary analysis of deidentified data for all payers from 53 centers registered in the HBOTR from 2013 to 2022. We estimated the mean annual per-patient costs of HBO2 based on Medicare (outpatient facility + physician) reimbursement fees adjusted to 2022 inflation using the Medicare Economic Index. Costs were calculated for the annual average number of treatments patients received each year and for a standard 40-treatment series. We estimated the 2022 costs of standard treatment protocols for HBO2 indications treated in the outpatient setting.
UNASSIGNED: Generally, all costs decreased from 2013 to 2022. The facility cost per patient per 40 HBO2 treatments decreased by 10.7% from $21,568.58 in 2013 to $19,488.00 in 2022. The physician cost per patient per 40 treatments substantially decreased by -37.8%, from $5,993.16 to $4,346.40. The total cost per patient per 40 treatments decreased by 15.6% from $27,561.74 to $23,834.40. In 2022, a single HBO2 session cost $595.86. For different indications, estimated costs ranged from $2,383.4-$8,342.04 for crush injuries to $17,875.80-$35,751.60 for diabetic foot ulcers and delayed radiation injuries.
UNASSIGNED: This real-world analysis of registry data demonstrates that the actual cost of HBO2 is not nearly as costly as the literature has insinuated, and the per-patient cost to Medicare is decreasing, largely due to decreased physician costs.
摘要：
■分析高压氧治疗注册（HBOTR）数据，以根据标准治疗方案和注册所报告的每位患者的年平均治疗次数估算高压氧治疗（HBO2）的医疗保险费用。
■我们对2013年至2022年在HBOTR注册的53个中心的所有付款人的未识别数据进行了二次分析。我们根据Medicare（门诊设施+医生）报销费用，使用Medicare经济指数调整到2022年通货膨胀，估计了HBO2的平均每年每位患者费用。根据每年接受治疗的患者的年平均数量和标准40治疗系列计算费用。我们估计了2022年门诊治疗HBO2适应症的标准治疗方案的成本。
■一般来说，从2013年到2022年，所有成本都有所下降。每40例HBO2治疗的每位患者的设施费用从2013年的21,568.58美元下降到2022年的19,488.00美元，下降了10.7％。每位患者每40次治疗的医师费用大幅下降-37.8%，从5,993.16美元到4,346.40美元。每位患者每40次治疗的总费用从27,561.74美元下降到23,834.40美元，下降了15.6%。2022年，一个HBO2会议的费用为595.86美元。对于不同的适应症，估计费用从挤压伤的$2,383.4-$8,342.04到糖尿病足溃疡和延迟放射损伤的$17,875.80-$35,751.60不等。
■对注册数据的实际分析表明，HBO2的实际成本并不像文献所暗示的那样昂贵，医疗保险的每位患者费用正在下降，主要是由于医生费用下降。
■我们对2013年至2022年在HBOTR注册的53个中心的所有付款人的未识别数据进行了二次分析。我们根据Medicare（门诊设施+医生）报销费用，使用Medicare经济指数调整到2022年通货膨胀，估计了HBO2的平均每年每位患者费用。根据每年接受治疗的患者的年平均数量和标准40治疗系列计算费用。我们估计了2022年门诊治疗HBO2适应症的标准治疗方案的成本。
■一般来说，从2013年到2022年，所有成本都有所下降。每40例HBO2治疗的每位患者的设施费用从2013年的21,568.58美元下降到2022年的19,488.00美元，下降了10.7％。每位患者每40次治疗的医师费用大幅下降-37.8%，从5,993.16美元到4,346.40美元。每位患者每40次治疗的总费用从27,561.74美元下降到23,834.40美元，下降了15.6%。2022年，一个HBO2会议的费用为595.86美元。对于不同的适应症，估计费用从挤压伤的$2,383.4-$8,342.04到糖尿病足溃疡和延迟放射损伤的$17,875.80-$35,751.60不等。
■对注册数据的实际分析表明，HBO2的实际成本并不像文献所暗示的那样昂贵，医疗保险的每位患者费用正在下降，主要是由于医生费用下降。
